当前位置:首页 - 行情中心 - 柳药集团(603368) - 财务分析

柳药集团

(603368)

  

流通市值:75.94亿  总市值:76.35亿
流通股本:3.60亿   总股本:3.62亿

柳药集团(603368)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润7.20亿元,每股收益1.86元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益687950.84万元,未分配利润372838.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2073666.50万元,负债1385715.66万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入15,616,596,259.210,344,037,758.695,334,761,606.2719,052,830,880.56
营业总成本14,704,296,293.489,751,974,645.834,984,984,145.5718,126,740,892.56
营业利润842,036,630.07545,727,695.8308,863,363.22890,060,946.22
利润总额841,749,229.83545,658,003.85309,028,912.6890,401,478.7
净利润719,540,098.92472,989,336.52270,305,830.3758,975,973.69
其他综合收益----
综合收益总额719,540,098.92472,989,336.52270,305,830.3758,975,973.69
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计18,306,344,361.2618,501,673,647.3116,421,324,203.6516,125,160,344.54
非流动资产合计2,430,320,618.462,400,434,603.782,484,195,654.482,481,831,302.37
资产总计20,736,664,979.7220,902,108,251.0918,905,519,858.1318,606,991,646.91
流动负债合计12,408,401,358.4212,834,253,765.7210,800,337,762.2510,827,717,511.04
非流动负债合计1,448,755,252.871,434,897,660.971,482,304,369.031,413,926,229.59
负债合计13,857,156,611.2914,269,151,426.6912,282,642,131.2812,241,643,740.63
归属于母公司股东权益合计6,439,684,911.016,208,079,874.16,217,260,643.275,968,964,510.96
股东权益合计6,879,508,368.436,632,956,824.46,622,877,726.856,365,347,906.28
负债和股东权益合计20,736,664,979.7220,902,108,251.0918,905,519,858.1318,606,991,646.91
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计16,916,527,014.0711,109,889,334.164,568,493,101.0821,546,029,509.43
经营活动现金流出小计16,897,013,115.7111,377,809,400.845,110,919,433.821,039,598,871.62
经营活动产生的现金流量净额19,513,898.36-267,920,066.68-542,426,332.72506,430,637.81
投资活动现金流入小计18,544,357.2714,614,331.053,016,565.65616,664,313.64
投资活动现金流出小计126,209,346.4750,553,550.5557,832,791.591,000,098,447.13
投资活动产生的现金流量净额-107,664,989.2-35,939,219.5-54,816,225.94-383,434,133.49
筹资活动现金流入小计3,838,787,714.83,353,031,470.731,248,784,863.596,614,880,578.93
筹资活动现金流出小计4,395,714,769.593,053,520,932.121,419,294,241.117,346,004,301.84
筹资活动产生的现金流量净额-556,927,054.79299,510,538.61-170,509,377.52-731,123,722.91
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-645,078,145.63-4,348,747.57-767,751,936.18-608,127,218.59
期末现金及现金等价物余额2,008,554,909.182,649,284,307.241,885,881,118.632,653,633,054.81
最新报告期:2024-03-20
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华泰证券代雯,孔垂岩,王殷杰2.342.813.382024-03-20
TOP↑